Skip to main content
Premium Trial:

Request an Annual Quote

Institut Pasteur Korea, Thermo Fisher to Co-Develop Drug Target-Identification Technology

Premium

Institut Pasteur Korea said this week that it has signed a deal with Thermo Fisher Scientific to co-develop RNAi reagents and services for use with the institute's PhenomicID genome-wide arrays for drug target identification.

Specific terms of the arrangement were not disclosed.

“Integrating … Thermo Scientific Dharmacon products and services with PhenomicID will provide an extremely effective plug-and-play solution for use in academic, biotech, and pharmaceutical labs for rapid identification of target compounds,” Devin Leake, director of research and development for genomics products at Thermo Fisher Scientific, said in a statement.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.